UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 1)* Corrected^[1]

Mindray Medical International Ltd.

(Name of Issuer)

(Title of Class of Securities)

602675100

May 31, 2010^[2]

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

þ Rule 13d-1(b)
o Rule 13d-1(c)
o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

^[1]  This Corrected Schedule 13G/A1 is being filed to correct the Schedule 13G/A1 filed by the reporting persons on September 30, 2010, which inadvertently included a calculation error with respect to certain holdings reported therein. Upon discovering this error, the reporting persons promptly took steps to file this Corrected Schedule 13G/A1.

^[2]  As a result of an administrative error, the reporting persons did not identify the securities reported herein as requiring a filing on Schedule 13G at the time the reporting persons exceeded the filing threshold. Upon discovering this oversight, the reporting persons promptly took steps to file this Schedule 13G, which speaks as of May 31, 2010.

 

 

CUSIP No.		602675100	13G	Page		2		of		12

* This Corrected Schedule 13G/A1 is being filed to correct the Schedule 13G/A1 filed on September 30, 2010, which inadvertently misstated the holding of this reporting person as 9,192,452 shares.

CUSIP No.		602675100	13G	Page		3		of		12

* This Corrected Schedule 13G/A1 is being filed to correct the Schedule 13G/A1 filed on September 30, 2010, which inadvertently misstated the holding of this reporting person as 9,192,452 shares.

CUSIP No.		602675100	13G	Page		4		of		12

* This Corrected Schedule 13G/A1 is being filed to correct the Schedule 13G/A1 filed on September 30, 2010, which inadvertently misstated the holding of this reporting person as 9,192,452 shares.

CUSIP No.		602675100	13G	Page		5		of		12

CUSIP No.		602675100	13G	Page		6		of		12

Item 1(a)		Name of Issuer: Mindray Medical International Limited

Item 1(b)		Address of Issuer’s Principal Executive Offices:

Mindray Building
Keji 12th Road South
Hi-tech Industrial Park,
Nanshan, Shenzhen 518057

Item 2(a)		Name of Person Filing

Item 2(b)		Address of Principal Business Office

Item 2(c)		Citizenship

Commonwealth Bank of Australia
Ground Floor, Tower 1
201 Sussex Street
Sydney, New South Wales, 2000
Commonwealth of Australia
Australian Capital Territory

Colonial Holding Company Limited
Ground Floor, Tower 1
201 Sussex Street
Sydney, New South Wales, 2000
Commonwealth of Australia
New South Wales

Commonwealth Insurance Holdings Limited
Ground Floor, Tower 1
201 Sussex Street
Sydney, New South Wales, 2000
Commonwealth of Australia
New South Wales

Colonial First State Group Limited
Ground Floor, Tower 1
201 Sussex Street
Sydney, New South Wales, 2000
Commonwealth of Australia
Victoria

Item 2(d)		Title of Class of Securities:

Class A Ordinary Shares, HK $0.001 par value per share

Item 2(e)		CUSIP Number: 602675100

Item 3		If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

	(a)	o	Broker or dealer registered under Section 15 of the Exchange Act;
	(b)	o	Bank as defined in Section 3(a)(6) of the Exchange Act;
	(c)	o	Insurance company as defined in Section 3(a)(19) of the Exchange Act;
	(d)	o	Investment company registered under Section 8 of the Investment Company Act;
	(e)	o	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
	(f)	o	An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
	(g)	þ	A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
	(h)	o	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
	(i)	o	A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
	(j)	o	A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
	(k)	o	Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J), please specify the type of institution:

If this statement is filed pursuant to Rule 13d-1(c), check this box: o

Item 4		Ownership:

(a)

Amount beneficially owned:

     Incorporated by reference to Item 9 of the cover page pertaining to each reporting person.

(b)

Percent of Class:

     Incorporated by reference to Item 11 of the cover page pertaining to each reporting person.

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote:

Incorporated by reference to Item 5 of the cover page pertaining to each reporting person.

(ii)

shared power to vote or to direct the vote:

Incorporated by reference to Item 6 of the cover page pertaining to each reporting person.

(iii)

sole power to dispose or to direct the disposition of:

Incorporated by reference to Item 7 of the cover page pertaining to each reporting person.

(iv)

shared power to dispose or to direct the disposition of:

Incorporated by reference to Item 8 of the cover page pertaining to each reporting person.

Item 5		Ownership of Five Percent or Less of a Class:

Not Applicable.

Item 6		Ownership of More than Five Percent on Behalf of Another Person:

Not Applicable.

Item 7		Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company:

See Exhibit 99.2.

Item 8		Identification and Classification of Members of the Group:

Not Applicable.

Item 9		Notice of Dissolution of Group:

Not Applicable.

Item 10 Certification:

     By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. I also certify that, to the best of my knowledge and belief, the foreign regulatory schemes applicable to the relevant subsidiaries referenced in Exhibit 99.2 to this Schedule 13G are substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s), and that I undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

     After reasonable inquiry and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated this 21st day of October, 2010.

Commonwealth Bank of Australia
By:		/s/ John Damien Hatton
Name:  John Damien Hatton
Title:    Company Secretary
Colonial Holding Company Limited
By:		/s/ John Damien Hatton
Name:  John Damien Hatton
Title:    Director
Commonwealth Insurance Holdings Limited
By:		/s/ John Damien Hatton
Name:  John Damien Hatton
Title:    Director
Colonial First State Group Limited
By:		/s/ John Damien Hatton
Name:  John Damien Hatton
Title:    Director

INDEX TO EXHIBITS

Exhibit No.		Exhibit
99.1		Joint Filing Agreement
99.2		Item 7 Information